United States · FDA National Drug Code directory
PROPOFOL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0641-6196_113ac304-ef02-4891-ac8b-8788f4ea041c
- Product NDC
- 0641-6196
- Form
- INJECTION, EMULSION
- Composition / generic term
- PROPOFOL
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200501
- Source listing expiry
- 20261231
Source-listed ingredients
- PROPOFOL — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-USE in 1 CARTON (0641-6196-10) / 100 mL in 1 VIAL, SINGLE-USE (0641-6196-01) · 0641-6196-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →